| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Urogen Pharma Ltd. (URGN) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. URGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 153.2K | $5.36M | - | |
| Other | 55.6K | $1.95M | - | |
| Dir | 20.0K | $699.8K | - | |
| CFO | 2.3K | $79.8K | - | |
| Dir | 2.0K | $70.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2021 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 243 | $20.00 | $4,860.00 | -1.1% | -20.4% | -63.7% | |
| Apr 26, 2021 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 89 | $19.63 | $1,747.07 | -0.4% | -26.5% | -65.1% | |
| Jan 31, 2021 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 1,076 | $22.07 | $23,747.32 | -4.9% | - | - | |
| Jan 26, 2021 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 100 | $22.12 | $2,212.00 | -0.5% | - | - | |
| Dec 14, 2020 | Barrett Elizabeth A. | Chief Executive Officer | Buy | 10,000 | $18.50 | $185,000.00 | +4.6% | - | - | |
| Dec 4, 2020 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 662 | $19.85 | $13,140.70 | -3.2% | - | - | |
| Oct 26, 2020 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 101 | $20.95 | $2,115.56 | -0.5% | - | - | |
| Oct 15, 2020 | Pfreundschuh Peter P.82 | Chief Financial Officer | Sale+OE | 2,400 | $21.77 | $52,247.75 | -6.7% | - | - | |
| Sep 4, 2020 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 348 | $20.20 | $7,029.60 | -1.8% | - | - | |
| Sep 1, 2020 | Pfreundschuh Peter P.82 | Chief Financial Officer | Sale+OE | 509 | $22.82 | $11,615.38 | -6.1% | - | - |